Jun 2026 (Q2 FY26) — Jul 30, 2026
Steven Madden, Ltd. Q2 FY26 — Robust Top and Bottom Line Growth Driven by Flagship Brand
Read the full callSteven Madden (SHOO) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Steven Madden earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 666 | +19.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.9 | +13.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 27.7 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$46.24 +3.35% · +$1.5
Performance +32.3% 1Y
1Y: $34.96 on 14 Oct 2025 → $46.24. High $49.07 (5 Aug 2026), low $31.37 (13 Mar 2026).
- Previous close
- $44.74
- 52-week range
- $31.37 – $49.07
- One year
- +30.84%
Overview
- Symbol
- SHOO
- Sector
- Consumer Discretionary
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Steven Madden earnings calls (SHOO)
Financials
What the filings say
Net profit, year on year: +170% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 625 | 582 | 554 | 559 | 668 | 754 | 653 | 666 |
| Operating profit | 75 | 47 | 53 | -40 | 31 | 36 | 99 | 39 |
| Operating margin | 11.9% | 8.0% | 9.7% | −7.2% | 4.7% | 4.8% | 15.1% | 5.9% |
| Profit before tax | 76 | 48 | 54 | -35 | 26 | 32 | 95 | 38 |
| Tax rate | 25.5% | 21.2% | 24.1% | −11.2% | 17.4% | 22.3% | 24.7% | 26.6% |
| Net profit | 55 | — | 40 | -39 | 21 | — | 72 | 28 |
| EPS ($ per share) | 0.78 | — | 0.57 | -0.56 | 0.29 | — | 1.01 | 0.39 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 1,218 | 1,310 | 1,280 | 1,421 | 1,571 | 1,680 | 1,788 | 1,772 |
| Total liabilities | 258 | 437 | 347 | 535 | 414 | 500 | 536 | 1,010 |
| Fixed assets | 65 | 66 | 43 | 36 | 41 | 47 | 57 | 116 |
| Investments | — | — | 39 | 44 | 15 | 15 | 13 | 0 |
| Total assets | 1,073 | 1,279 | 1,138 | 1,356 | 1,258 | 1,348 | 1,412 | 1,914 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 154 | 234 | 44 | 159 | 268 | 229 | 198 | 162 |
| Cash from investing | 11 | -28 | -5 | -3 | 6 | -100 | -39 | -401 |
| Cash from financing | -146 | -142 | -57 | -185 | -216 | -201 | -168 | 157 |
| Net cash flow | — | 64 | -16 | -28 | 55 | -70 | -15 | -78 |
| Capital expenditure | -12 | -18 | -7 | -7 | -16 | -19 | -26 | -43 |
| Free cash flow | 142 | 215 | 38 | 153 | 252 | 210 | 172 | 120 |
Insider filings
56 filings between Nov 12, 2025 and Aug 5, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$3.92M
19 sales by 9 insiders
Compensation
not trading decisions- 13
- Award — granted as compensation
- 24
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| VARELA AMELIA | — | $1.80M | Aug 5, 2026 |
| Mazouzi Zine | — | $526.5K | Nov 25, 2025 |
| Reed Arian Simone | — | $399.4K | Aug 5, 2026 |
| MIGLIORINI PETER | — | $307.6K | Jun 15, 2026 |
| Ciglar Christina | — | $230.3K | Jun 9, 2026 |
| KLIPPER MITCHELL S | — | $190.2K | Aug 5, 2026 |
| Ferrara Al | — | $189.1K | Aug 4, 2026 |
| Davis Peter Allan | — | $178.5K | Aug 4, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Reed Arian Simone Director | Sale | 1,250 | $61.0K |
| Aug 5, 2026 | VARELA AMELIA President | Sale | 15,000 | $728.8K |
| Aug 5, 2026 | KLIPPER MITCHELL S Director | Sale | 3,918 | $190.2K |
| Aug 4, 2026 | Davis Peter Allan Director | Sale | 525 | $25.4K |
| Aug 4, 2026 | Ferrara Al Director | Sale | 3,918 | $189.1K |
| Aug 1, 2026 | Keith Lisa EVP, Gen. Counsel, Secretary | Tax withheld | 581 | $26.8K |
| Jun 15, 2026 | Reed Arian Simone Director | Sale | 1,100 | $49.9K |
| Jun 15, 2026 | MIGLIORINI PETER Director | Sale | 4,000 | $181.2K |
| Jun 9, 2026 | Ciglar Christina Chief Product Officer | Sale | 5,147 | $230.3K |
| Jun 4, 2026 | Reed Arian Simone Director | Sale | 475 | $20.8K |
| Jun 3, 2026 | VARELA AMELIA President | Sale | 10,000 | $434.4K |
| May 22, 2026 | Davis Peter Allan Director | Sale | 3,030 | $127.2K |
| May 20, 2026 | Davis Peter Allan Director | Award | 2,964 | $0 |
| May 20, 2026 | Ferrara Al Director | Award | 2,964 | $0 |
| May 20, 2026 | KLIPPER MITCHELL S Director | Award | 2,964 | $0 |
| May 20, 2026 | Kumar Maria Teresa Director | Award | 2,964 | $0 |
| May 20, 2026 | MIGLIORINI PETER Director | Award | 2,964 | $0 |
| May 20, 2026 | LYNCH ROSE PEABODY Director | Award | 2,964 | $0 |
| May 20, 2026 | Sachdev Ravi Director | Award | 2,964 | $0 |
| May 20, 2026 | Reed Arian Simone Director | Sale | 648 | $25.9K |
| May 20, 2026 | Reed Arian Simone Director | Award | 2,964 | $0 |
| Mar 15, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 713 | $22.4K |
| Mar 15, 2026 | Keith Lisa EVP, Gen. Counsel, Secretary | Award | 1,594 | $0 |
| Mar 15, 2026 | Keith Lisa EVP, Gen. Counsel, Secretary | Tax withheld | 143 | $4.5K |
| Mar 15, 2026 | Mazouzi Zine Chief Financial Officer | Award | 7,969 | $0 |
| Mar 15, 2026 | Rosenfeld Edward R. Chief Executive Officer | Award | 108,384 | $0 |
| Mar 15, 2026 | VARELA AMELIA President | Award | 7,969 | $0 |
| Mar 15, 2026 | VARELA AMELIA President | Tax withheld | 1,010 | $31.7K |
| Mar 12, 2026 | Reed Arian Simone Director | Sale | 3,600 | $120.4K |
| Mar 1, 2026 | Keith Lisa EVP, Gen. Counsel, Secretary | Tax withheld | 94 | $3.4K |
| Mar 1, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 365 | $13.2K |
| Mar 1, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 465 | $16.8K |
| Mar 1, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 520 | $18.8K |
| Mar 1, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 433 | $15.6K |
| Mar 1, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 9,565 | $345.3K |
| Mar 1, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 5,594 | $201.9K |
| Mar 1, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 8,554 | $308.8K |
| Mar 1, 2026 | VARELA AMELIA President | Tax withheld | 659 | $23.8K |
| Mar 1, 2026 | VARELA AMELIA President | Tax withheld | 736 | $26.6K |
| Mar 1, 2026 | VARELA AMELIA President | Tax withheld | 614 | $22.2K |
| Feb 28, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 9,033 | $326.1K |
| Feb 28, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 12,928 | $466.7K |
| Feb 1, 2026 | Keith Lisa EVP, Gen. Counsel, Secretary | Tax withheld | 1,589 | $69.7K |
| Feb 1, 2026 | Rosenfeld Edward R. Chief Executive Officer | Tax withheld | 4,992 | $219.0K |
| Jan 7, 2026 | VARELA AMELIA President | Award | 24,983 | $0 |
| Jan 4, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 2,102 | $88.7K |
| Jan 3, 2026 | VARELA AMELIA President | Tax withheld | 4,718 | $199.1K |
| Jan 2, 2026 | Mazouzi Zine Chief Financial Officer | Tax withheld | 1,933 | $81.6K |
| Dec 11, 2025 | Reed Arian Simone Director | Sale | 2,712 | $121.5K |
| Dec 1, 2025 | VARELA AMELIA President | Sale | 15,000 | $638.8K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for STEVEN MADDEN, LTD.
Free account. Everything above stays public.
Write why you follow STEVEN MADDEN, LTD. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading